newsfilter
← Latest News
Business Wire·

Fulgent Genetics Completes Acquisition of Bako Diagnostics and StrataDx

Fulgent Genetics, Inc. (NASDAQ:FLGT) ("Fulgent"), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced the completion of the acquisition